Monotherapy or polytherapy for childhood epilepsies?

Arch Dis Child

School of Medicine, University of Nottingham, Nottingham, UK Department of Paediatric Neurology, Nottingham Children's Hospital, Nottingham University Hospitals' NHS Trust, Nottingham, UK.

Published: April 2016

Download full-text PDF

Source
http://dx.doi.org/10.1136/archdischild-2015-309466DOI Listing

Publication Analysis

Top Keywords

monotherapy polytherapy
4
polytherapy childhood
4
childhood epilepsies?
4
monotherapy
1
childhood
1
epilepsies?
1

Similar Publications

Objectives: This study aimed to explore the effect of antiseizure medications (ASM) on thyroid function in children with epilepsy.

Methods: A prospective study involving children between 6 months and 12 years of age with new-onset seizures who took ASM within 2 months was conducted in the Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India, between August 2019 to March 2022. Thyroid function tests-free T3, free T4 and thyroid stimulating hormone (TSH)-were done at baseline and after completing 3 months by competitive immunoassay using direct chemiluminescent technology.

View Article and Find Full Text PDF

Impact of interaction among antiseizure medication polytherapy, clinical, sociodemographic and psychological factors on quality of life in patients with epilepsy: A systematic review.

Epilepsy Behav

January 2025

Institut d'Investigació en Psicologia dels Recursos Humans, del Desenvolupament Organitzacional i de La Qualitat de Vida Laboral (IDOCAL)/Department of Psychobiology, Psychology Center, Universitat de València, Valencia, Spain. Electronic address:

Introduction: Drug-resistant epilepsy usually requires the use of polytherapy with antiseizure medications (ASMs) for management, which could involve side and adverse effects that may impact quality of life (QOL). This systematic review summarizes the evidence about the relationship between ASM polytherapy and QOL in epilepsy patients, considering clinical, sociodemographic, and psychological variables.

Method: This review followed the PRISMA guidelines and was registered in PROSPERO.

View Article and Find Full Text PDF
Article Synopsis
  • The study examines the use of antiseizure medications (ASMs) among pregnant individuals in four Canadian provinces over 20 years, focusing on trends and patterns in ASM usage among those with and without epilepsy.
  • Results showed that only 0.7% of the pregnant population had epilepsy, with 1.7% exposed to ASMs; notable increases in ASM use were observed among those without epilepsy, especially in Manitoba, Saskatchewan, and Alberta.
  • The analysis also revealed shifts in ASM drug classes, with a decline in older medications like carbamazepine and a rise in newer options like lamotrigine, while usage patterns varied by province and trimester.
View Article and Find Full Text PDF

A new era in cancer therapy emerged with the arrival of immune-checkpoint inhibitors (ICIs), followed by a new cadre of immune-related adverse events that affect up to 40% of patients. Literature on the pathological features associated with these events is still limited. Therefore, to expand our knowledge of the histopathologic spectrum of pulmonary changes, we conducted a case study series analysis on 16 non-neoplastic lung samples collected during or after ICI therapy.

View Article and Find Full Text PDF

Background: Antiseizure medications (ASMs) are crucial for managing epilepsy in children. However, a well-documented side effect of ASMs is their impact on bone health, often due to interference with vitamin D metabolism. This can lead to vitamin D deficiency in children with epilepsy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!